Movers

12 Information Technology Stocks Moving In Friday's Intraday Session

Posted on: Friday, November 14, 2025 - 12:06pm

All terms: Movers

Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal

Posted on: Friday, November 14, 2025 - 11:37am

Avadel reviews Lundbeck's unsolicited $23 offer while maintaining its agreement with Alkermes as its board evaluates whether the new proposal could be superior.

All terms: Biotech, M&A, News, Health Care, Top Stories, Movers, Trading Ideas, General

Applied Materials Bounces Back As Analysts Boost Targets On Strong Q4

Posted on: Friday, November 14, 2025 - 11:33am

Shares of Applied Materials are up after reporting upbeat Q4 results. Analysts from JPMorgan, Needham and Goldman Sachs maintain positive ratings on the stock with price targets ranging from $250-$260.

All terms: Analyst Color, Earnings, Earnings Beats, Equities, Price Target, Reiteration, Analyst Ratings, Movers, Tech

What's Going On With Applied Materials Shares Friday?

Posted on: Friday, November 14, 2025 - 11:33am

Applied Materials shares are trading flat Friday. The company reported fourth-quarter financial results on Thursday after the market closed.

All terms: News, Movers

Twist Bioscience Eyes Profit Turnaround In 2026 After Narrowing Losses

Posted on: Friday, November 14, 2025 - 11:29am

Twist Bioscience reports mixed Q4 earnings with a loss of 45 cents, sales of $99.01 million beating consensus.

All terms: Analyst Color, Earnings, News, Guidance, Health Care, Top Stories, Analyst Ratings, Movers, Trading Ideas, General

What's Going On With StubHub Shares Friday?

Posted on: Friday, November 14, 2025 - 11:23am

The window of a StubHub office in midtown Manhattan.

Multiple analysts cut their price targets on StubHub following a worse-than-expected third-quarter earnings report.

All terms: News, Movers

Bristol Myers Faces Another Trial Disappointment As Heart Drug Milvexian Fails To Show Efficacy

Posted on: Friday, November 14, 2025 - 11:17am

Bristol Myers and Johnson & Johnson ended the Librexia ACS trial after an interim review showed low efficacy, while AF and stroke studies continue with data expected in 2026.

All terms: Analyst Color, Biotech, Large Cap, News, Health Care, Top Stories, Analyst Ratings, Movers, Trading Ideas, General

SEALSQ Expands Made-In-USA Strategy With New Quantum-Safe Security Platform

Posted on: Friday, November 14, 2025 - 11:07am

A glowing digital lock surrounded by streams of binary code and data points, symbolizing cybersecurity.

SEALSQ Corp (LAES) announced launch of US-based Post-Quantum Root of Trust platform, strengthening US cybersecurity.

All terms: News, Top Stories, Movers, Tech

Walt Disney Streams Revenue Miss, Weak Guidance: These Analysts Raise Projections

Posted on: Friday, November 14, 2025 - 11:07am

Disappointing results for Disney as revenues miss expectations and DTC earnings underperform.

All terms: Analyst Color, Earnings, Earnings Beats, Entertainment, Equities, Price Target, Reiteration, Top Stories, Analyst Ratings, Movers

Estée Lauder Bottles A Mexican Mood With XINÚ Stake

Posted on: Friday, November 14, 2025 - 11:00am

Estée Lauder shares eased Friday after the company made its first Latin American investment, taking a minority stake in Mexican fragrance brand XINÚ.

All terms: Equities, News, Markets, Movers, General